Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

National Institutes of Health is offering a funding call in United States. Applications close on May 7, 2028.

Apply on the issuer's website

At a glance

Type
Funding
Offered by
National Institutes of Health (Public funding)
Where
United States
Closes
May 7, 2028
How to apply
On the issuer's own website

More from National Institutes of Health

Similar offers in United States

All sections

Edition